that assessment of analyte stability and matrix effects must be part of every assay validation.
It is, however, essential that validation is done with the assay under consideration, as
different lipoarabinomannan (LAM) assays use different reagents that bind to different LAM
epitopes with different stabilities or availabilities. Therefore, results from the research assay
described by Connelly and colleagues,